Research on PCOS & Fibroids in BIPOC Communities

The World Health Organization's global reference on PCOS, revised on 22 January 2026. The revision raised the estimated prevalence to 10 to 13 percent of women of reproductive age and restated how much of the condition still goes unrecognized.

The global consensus paper that renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome, published 12 May 2026.

Public announcement from the Endocrine Society explaining that the condition long known as polycystic ovary syndrome has been renamed Polyendocrine Metabolic Ovarian Syndrome.

United Kingdom draft clinical guideline documentation that adopts the new PMOS terminology and adapts the Monash international evidence based guideline.

Cohort study of nearly 2 million patients examining differences in fibroid diagnosis rates across racial and ethnic groups from 2009-2022.

Scoping review examining fibroid prevalence, risk factors, and outcomes for Caribbean and African women in the UK healthcare system.

Review examining phenotypic disparities of PCOS among various racial and ethnic populations, highlighting the need for personalized approaches.

A comprehensive scoping review examining the global burden of uterine fibroids among Black women of African descent, highlighting significant health disparities.

Editorial examining the unique burden of uterine fibroids in Black women, emphasizing the intersection of biological and social determinants of health.

Global burden analysis examining trends in gynecological conditions including PCOS and fibroids across different populations and regions.

Policy analysis examining PCOS through a reproductive justice lens, highlighting systemic barriers faced by Black women.

Investigative report examining factors contributing to PCOS underdiagnosis in Black women, including healthcare bias and access barriers.

Pooled the randomized trials that tested vitamin D supplements against placebo in women with fibroids, giving the clearest picture available of whether supplementing actually changes fibroid size.

Reviews the trial evidence on omega-3 fats in PCOS and the biological pathways through which they act on insulin resistance and inflammation.

Combined vitamin D supplementation trials in PCOS to answer a practical question: how much vitamin D is needed to move blood levels into a sufficient range.

Comprehensive review of racial and ethnic disparities in PCOS diagnosis, presentation, and treatment outcomes.

Qualitative study exploring perceptions and lived experiences of women with PCOS across different age groups and ethnicities.

Analysis of PCOS self-reporting patterns in a diverse cohort from the CARDIA study, examining racial and socioeconomic factors.

Comprehensive review examining uterine fibroids from an African perspective, addressing unique challenges and treatment approaches.

Systematic review of racial differences in uterine fibroids and endometriosis, read through the social, structural and political conditions that shape who gets diagnosed and treated well.

Review of how racial disparities show up across the whole infertility journey, not only in treatment success rates, framed through reproductive justice.

The international guideline that most clinicians now follow. It places nutrition and lifestyle as first line care for PCOS/PMOS rather than an afterthought.

A review of how carbohydrate quality affects insulin resistance, androgens and ovulation in PCOS, and what that means for building a practical plate.

Pooled randomized trials of omega-3 supplementation in PCOS to measure the size of the effect on insulin, cholesterol and inflammation.

The Study of Environment, Lifestyle and Fibroids followed Black women with repeat ultrasounds to see whether vitamin D status changed how fibroids grew over time, not just whether they were present.

Retrospective cohort at two United States fertility clinics comparing tubal factor infertility diagnoses and in vitro fertilization outcomes across racial groups.

National online survey of 471 college attending women in the United States measuring how often they could not afford menstrual products and how that tracked with depression.

Pooled randomized trials testing probiotic and synbiotic supplements against placebo in women with PCOS, focused on insulin resistance measures.

Used standardized ultrasounds instead of clinical diagnosis so that fibroids in women without symptoms were still counted, then compared results against detailed diet records.

Compared women with PCOS against matched controls on how closely they followed a Mediterranean eating pattern, along with body composition and markers of inflammation.

A 24 week intervention testing whether the same calorie restricted low glycemic index diet works differently for women with PCOS than for women without it.

Asked whether phytoestrogen exposure during infancy through soy formula shows up decades later as ultrasound detected fibroids in young Black women.

Examined whether the type of fat in the diet, rather than total fat, is related to fibroid development in Black women followed for over a decade.

Community based ultrasound study of 1,036 women ages 35 to 49 that measured blood vitamin D and screened every participant for fibroids, so cases were not missed because of symptoms alone.

A four month placebo controlled pilot trial of 800 mg a day of green tea extract standardized to EGCG in women with symptomatic fibroids.

Ten years of follow up in the Black Women's Health Study, connecting what participants ate with ultrasound or surgery confirmed fibroid diagnoses.

Looked at whether dairy foods are related to fibroid risk in Black women, a group with both high fibroid rates and low average dairy intake.

A randomized trial comparing a low glycemic index diet with a conventional healthy diet of matched calories in women with PCOS, run until weight loss reached a set target.

One of the first case control studies to link everyday eating patterns with fibroids, comparing 843 women with confirmed fibroids against 1,557 without.